Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions
Jeffrey L. Cummings
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.neurot.2025.e00570
- Published
- Mar 20, 2025
- Venue
- Neurotherapeutics
- DOI
- 10.1016/j.neurot.2025.e00570
- PubMed
- 40118715
- Categories
- Alzheimer's disease research and treatments
- License
- cc-by-nc-nd
- Provenance
- openalex